Interferon Gamma (IFN-γ)
IFN-γ is a cytokine critical for innate and adaptive immunity against viral and intracellular bacterial infections and for tumor control. It is often used to evaluate immune responses and inflammation.
IFN-γ is a key immune system protein used to diagnose inflammatory conditions and infections.
Key facts at a glance
- Units
- pg/mL
- Clinical utility
- diagnostic
- Result kind
- quantitative
- FDA-cleared
- R&D Systems IFN-gamma ELISA, Meso Scale Discovery IFN-gamma
Interferon Gamma (IFN-γ) is a cytokine that plays a crucial role in the immune response against pathogens, particularly viruses and some bacteria. It is produced mainly by natural killer (NK) cells and T lymphocytes.
Measuring IFN-γ levels can help in diagnosing conditions related to immune system dysfunction, such as autoimmune disorders and severe infections. Elevated levels may indicate an active immune response or inflammation.
The reference range for IFN-γ is typically 0–5 pg/mL. Levels above this range may suggest an underlying inflammatory condition or infection that warrants further investigation.
Frequently asked questions
What conditions can cause elevated IFN-γ levels?
How is the IFN-γ test performed?
Sources
- 1
- 2
Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy